ImpriMed
ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology provides precision medicine techniques that allow veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment that can eventually be translated into human cancer care, allowing doctors to decide on a final treatment regimen based on a data-driven prediction of response success in each individual patient's body.
Domain
imprimedicine.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$23.0M
Founded
2017
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does ImpriMed use?+
ImpriMed uses 17 technologies including Google Analytics, Google Tag Manager, HubSpot.
What industry is ImpriMed in?+
ImpriMed operates in the Artificial Intelligence (AI) industry.
Where is ImpriMed based?+
ImpriMed is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026